Evaluating relapse prophylaxis in addition to interdisciplinary multimodal pain therapy for back pain: a randomised controlled trial
Journal of Rehabilitation Medicine · 2025
DOI: 10.2340/jrm.v57.42088 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Rehabilitation Medicine, 2025. Verfasst von Julia Schmetsdorf und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hannover Medical School, Institute for Epidemiology, Social Medicine, and Health Systems Research, Hannover, Germany; Centre for Health Economics Res…. Hauptthemen laut MEDLINE: Back Pain, Secondary Prevention. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aimed to evaluate the effectiveness of a 12-month relapse prophylaxis following a 4-week interdisciplinary multimodal pain therapy approach for patients with back pain. The study examined whether the intervention reduced days of incapacity to work (primary outcome) and improved functional capacity and health-related quality of life (secondary outcomes) compared with interdisciplinary multimodal pain therapy alone.
Design
A randomized controlled trial was conducted. The recruitment period was 24 months. Subjects/Patients: The study comprised 297 employed patients from a rural region in north-west Germany, diagnosed with back pain in different regions of the spine.
Methods
The analyses were based on quantitative data: claims data and questionnaire data.
Results
The results showed a mean of 70.07 days of incapacity to work after the interdisciplinary multimodal pain therapy for the control group and a lower mean of 56.41 days for the intervention group. The group difference was not significant (p = 0.259). Analysis of change scores revealed statistically significant larger improvements of functional capacity and health-related quality of life in the intervention group.
Conclusion
Findings of this study show improvements in the secondary outcomes. The results indicate that further studies are needed to determine how to sustainably reduce days off work due to back pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Hannover Medical School, Institute for Epidemiology, Social Medicine, and Health Systems Research, Hannover, Germany; Centre for Health Economics Research Hannover (CHERH), Hannover, Germany. Schmetsdorf.Julia@mh-hannov…
- Hannover Medical School, Institute for Epidemiology, Social Medicine, and Health Systems Research, Hannover, Germany; Centre for Health Economics Research Hannover (CHERH), Hannover, Germany.
- Hannover Medical School, Institute for Epidemiology, Social Medicine, and Health Systems Research, Hannover, Germany; AOK Niedersachsen, Hannover, Germany.
- Rehabilitation Centre, Outpatient department for orthopedic rehabilitation, Bad Zwischenahn, Germany.
- University of Greifswald, Institute for Community Medicine, Greifswald, Germany.
Zitieren
APA
Schmetsdorf, J., Krüger, K., Posselt, J., Werner, R., Zechel, H. G., Kohlmann, T., & Krauth, C. (2025). Evaluating relapse prophylaxis in addition to interdisciplinary multimodal pain therapy for back pain: a randomised controlled trial. Journal of Rehabilitation Medicine. https://doi.org/10.2340/jrm.v57.42088
Vancouver
Schmetsdorf J, Krüger K, Posselt J, Werner R, Zechel HG, Kohlmann T, et al. Evaluating relapse prophylaxis in addition to interdisciplinary multimodal pain therapy for back pain: a randomised controlled trial. Journal of Rehabilitation Medicine. 2025. doi:10.2340/jrm.v57.42088
BibTeX
@article{Schmetsdorf2025,
author = {Schmetsdorf, Julia and Krüger, Kathrin and Posselt, Jacqueline and Werner, Runde and Zechel, Hans-Georg and Kohlmann, Thomas and Krauth, Christian},
title = {Evaluating relapse prophylaxis in addition to interdisciplinary multimodal pain therapy for back pain: a randomised controlled trial},
journal = {Journal of Rehabilitation Medicine},
year = {2025},
doi = {10.2340/jrm.v57.42088}
}
EUVIMED